Analyst Recommendations
4.14 -0.16(-3.62%)09/06/2024
Sutro Biopharma Inc (STRO)
Sutro Biopharma Inc (STRO)
2024: Total Recommendations Consensus
To Grade | # of Recommendations |
---|---|
Outperform | 6 |
Buy | 5 |
Market Outperform | 2 |
Overweight | 1 |
5 records were shown. To view all data, Upgrade to PRO plan with only $1
Upgrades & Downgrades